Growth factors - Pharmaceutical Biotechnology: Concepts and Aapplications - page 289

Further reading
Books
Dallman, M. 2000. Haemopoietic and Lymphoid Cell Culture . Cambridge University Press.
Hoke, A. (ed.). 2006. Erythropoietin and the Nervous System . Springer Verlag.
Korholz, D. 2003. Cytokines and Colony Stimulating Factors . Humana Press.
Kuter, D., Hunt, P., Sheridan, W.P., and Zucker-Franklin, D. (eds). 1997. Thrombopoiesis and Thrombopoietins .
Humana Press.
McKay, I. 1998. Growth factors and receptors . Oxford University Press.
Medkalf, D. 1995. Haemopoietic Colony-Stimulating Factors: From Biology to Clinical Applications .
Cambridge University Press.
Morstyn, G. 1998. Filgrastim in Clinical Practice . Marcel Dekker.
Orlic, D. 1999. Haematopoietic Stem Cells . New York Academy of Science.
Patel, T. 2006. Epidermal Growth Factor . Humana Press.
Sytkowski, A. 2004. Erythropoietin . Wiley.
Yee, D. (ed.). 2004. Insulin-like Growth Factors . IOS Press.
Articles
Erythropoietin and thrombopoietin
Basser, R. 2002. The impact of thrombopoietin on clinical practice. Current Pharmaceutical Design 8 (5),
369-377.
Bottomley, A., Thomas, R., van Steen, K., Flechtner, H., Djulbegovic, B. 2002. Human recombinant erythropoietin
and quality of life: a wonder drug or something to wonder about? Lancet Oncology 3 (3), 145-153.
Buemi, M., Aloisi, C., Cavallaro, E., Corica, F., Floccari, F., Grasso, G., Lasco, A., Pettinato, G, Ruello, A.,
Sturiale, A., and Frisina, N. 2002. Recombinant human erythropoietin: more than just the correction of uremic
anemia. Journal of Nephrology 15 (2), 97-103.
Corwin, H. 2006. The role of erythropoietin therapy in the critically ill. Transfusion Medicine Reviews 20 (1),
27-33.
Engert, A. 2005. Recombinant human erythropoietin in oncology: current status and further developments.
Annals of Oncology 16 (10), 1584-1595.
Fried, W. 1995. Erythropoietin. Annual Review of Nutrition 15 , 353-377.
Geddis, A.E., Linden, H.M., and Kaushansky, K. 2002. Thrombopoietin: a pan-hematopoietic cytokine. Cytokine
and Growth Factor Reviews 13 (1), 61-73.
Heuser, M. and Ganser, A. 2006. Recombinant human erythropoietin in the treatment of nonrenal anemia. Annals
of Hematology 85 (2), 69-78.
Kaushansky, K. 1997. Thrombopoietin - understanding and manipulating platelet production. Annual Review of
Medicine 48 , 1-11.
Kaushansky, K. and Drachman, J. 2002. The molecular and cellular biology of thrombopoietin: the primary
regulator of platelet production. Oncogene 21 (21), 3359-3367.
Kaushansky, K. 2005. The molecular mechanisms that control thrombopoiesis. Journal of Clinical Investigation
115 (12), 3339-3347.
Kendall, R. 2001. Erythropoietin. Clinical and Laboratory Haematology 23 (2), 71-80.
Lok, S., Kaushansky, K., Holly, R.D., Kuijper, J.L., Lofton-Day, C.E., Oort, P.J., Grant, F.J., Heipel, M.D.,
Burkhead, S.K., Kramer, J.M., Bell, L.A., Sprecher, C.A., Blumberg, H., Johnson, R., Prunkard, D., Ching,
A.F.T., Mathewes, S.L., Bailey, M.C., Forstrom, J.W., Buddle, M.M., Osborn, S.G., Evans, S.J., Sheppard, P.O.,